$NSP
INSPERITY, INC. Stock $nsp

$nsp Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000100075324000034 Filed on May 01, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$1.605B	$1.802B	$1.770B
YoY Change	1.25%	1.83%	12.16%
Cost Of Revenue	$1.345B	$1.457B	$1.438B
YoY Change	-1.14%	1.36%	11.26%
Gross Profit	$260.0M	$345.0M	$332.1M
YoY Change	15.74%	3.87%	16.23%
Gross Profit Margin	16.2%	19.15%	18.77%
Selling, General & Admin	$226.0M	$226.0M	$200.6M
YoY Change	14.09%	12.64%	13.23%
% of Gross Profit	86.92%	65.51%	60.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$11.00M	$11.00M	$10.50M
YoY Change	2.42%	4.79%	3.07%
% of Gross Profit	4.23%	3.19%	3.16%
Operating Expenses	$237.0M	$237.0M	$211.1M
YoY Change	13.49%	12.25%	12.68%
Operating Profit	$23.00M	$108.0M	$121.0M
YoY Change	45.51%	-10.75%	22.98%
Interest Expense	$7.000M	$3.000M	$6.205M
YoY Change	447.3%	-51.65%	222.34%
% of Operating Profit	30.43%	2.78%	5.13%
Other Income/Expense, Net
YoY Change
Pretax Income	$25.00M	$111.0M	$123.6M
YoY Change	46.32%	-10.18%	27.9%
Income Tax	$7.000M	$32.00M	$28.98M
% Of Pretax Income	28.0%	28.83%	23.45%
Net Earnings	$18.00M	$79.00M	$94.60M
YoY Change	39.6%	-16.49%	35.36%
Net Earnings / Revenue	1.12%	4.38%	5.35%
Basic Earnings Per Share	$0.48	$2.11	$2.49
Diluted Earnings Per Share	$0.48	$2.08	$2.45
COMMON SHARES
Basic Shares Outstanding	37.66M shares	37.29M shares	37.85M shares
Diluted Shares Outstanding	38.00M shares	38.00M shares	38.67M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$692.0M	$683.0M	$732.1M
YoY Change	12.32%	-6.71%	20.17%
Cash & Equivalents	$676.0M	$667.0M	$696.6M
Short-Term Investments	$16.00M	$16.00M	$35.54M
Other Short-Term Assets	$91.00M	$212.0M	$79.86M
YoY Change	-30.48%	165.46%	-0.53%
Inventory
Prepaid Expenses
Receivables	$740.0M	$724.0M	$607.3M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.621B	$1.619B	$1.518B
YoY Change	18.87%	6.65%	6.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$186.0M	$247.0M	$196.4M
YoY Change	-24.08%	25.78%	-4.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$18.00M	$247.0M	$31.38M
YoY Change	-92.62%	687.1%	48.68%
Total Long-Term Assets	$474.0M	$507.0M	$521.9M
YoY Change	-5.51%	-2.85%	2.7%
TOTAL ASSETS
Total Short-Term Assets	$1.621B	$1.619B	$1.518B
Total Long-Term Assets	$474.0M	$507.0M	$521.9M
Total Assets	$2.095B	$2.126B	$2.040B
YoY Change	12.32%	4.22%	5.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.000M	$6.000M	$9.491M
YoY Change	2.84%	-36.78%	21.28%
Accrued Expenses	$72.00M	$1.385B	$79.79M
YoY Change	-93.62%	1635.74%	-7.89%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.383B	$1.406B	$1.303B
YoY Change	21.78%	7.91%	1.27%
LONG-TERM LIABILITIES
Long-Term Debt	$369.0M	$369.0M	$369.4M
YoY Change	-0.11%	-0.11%	0.0%
Other Long-Term Liabilities	$201.0M	$211.0M	$233.0M
YoY Change	-12.48%	-9.44%	-4.91%
Total Long-Term Liabilities	$570.0M	$580.0M	$603.6M
YoY Change	-4.85%	-3.91%	-2.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.383B	$1.406B	$1.303B
Total Long-Term Liabilities	$570.0M	$580.0M	$603.6M
Total Liabilities	$1.953B	$1.986B	$1.907B
YoY Change	12.58%	4.17%	0.02%
SHAREHOLDERS EQUITY
Retained Earnings	$788.0M	$793.0M	$726.1M
YoY Change	9.87%	9.21%	20.02%
Common Stock	$192.0M	$173.0M	$142.6M
YoY Change	21.46%	21.35%	28.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$838.0M	$826.0M	$735.2M
YoY Change	12.52%	12.35%	7.86%
Treasury Stock Shares
Shareholders Equity	$142.0M	$140.0M	$133.4M
YoY Change
Total Liabilities & Shareholders Equity	$2.095B	$2.126B	$2.040B
YoY Change	12.32%	4.22%	5.15%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$18.00M	$79.00M	$94.60M
YoY Change	39.6%	-16.49%	35.36%
Depreciation, Depletion And Amortization	$11.00M	$11.00M	$10.50M
YoY Change	2.42%	4.79%	3.07%
Cash From Operating Activities	$20.00M	$31.00M	$39.35M
YoY Change	-118.35%	-21.22%	-33.13%
INVESTING ACTIVITIES
Capital Expenditures	$6.000M	$5.000M	$6.849M
YoY Change	-16.29%	-27.0%	46.16%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$2.096M
YoY Change	-100.0%	-100.0%	74.09%
Cash From Investing Activities	-$6.000M	-$5.000M	-$8.945M
YoY Change	-18.32%	-44.1%	51.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-44.00M	-83.00M	-$46.85M
YoY Change	15.36%	77.17%	6.75%
NET CHANGE
Cash From Operating Activities	20.00M	31.00M	$39.35M
Cash From Investing Activities	-6.000M	-5.000M	-$8.945M
Cash From Financing Activities	-44.00M	-83.00M	-$46.85M
Net Change In Cash	-30.00M	-57.00M	-$16.44M
YoY Change	-80.58%	246.72%	-281.24%
FREE CASH FLOW
Cash From Operating Activities	$20.00M	$31.00M	$39.35M
Capital Expenditures	$6.000M	$5.000M	$6.849M
Free Cash Flow	$14.00M	$26.00M	$32.50M
YoY Change	-112.05%	-20.01%	-39.99%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1802000000	usd
CY2024Q1	nsp	Payroll Taxes Benefits And Workers Compensation Costs PayrollTaxesBenefitsAndWorkersCompensationCosts	1457000000	usd
CY2023Q1	nsp	Payroll Taxes Benefits And Workers Compensation Costs PayrollTaxesBenefitsAndWorkersCompensationCosts	1438000000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	332000000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	345000000	usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	nsp	Time Period Incurred Claims Expected To Be Paid Included In Deposits TimePeriodIncurredClaimsExpectedToBePaidIncludedInDeposits	Greater than 1 year
CY2024Q1	nsp	Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Long Term Liabilities TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInLongTermLiabilities	Greater than 1 year
CY2024Q1	nsp	Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Short Term Liabilities TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInShortTermLiabilities	P1Y
CY2024Q1	nsp	Time Period Incurred Claims Expected To Be Paid Recorded As Restricted TimePeriodIncurredClaimsExpectedToBePaidRecordedAsRestricted	P1Y
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	nsp	Salaries Wages And Payroll Taxes SalariesWagesAndPayrollTaxes	140000000	usd
CY2023Q1	nsp	Salaries Wages And Payroll Taxes SalariesWagesAndPayrollTaxes	125000000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11000000	usd
CY2024Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	12000000	usd
CY2023Q1	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	11000000	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	7000000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	6000000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	57000000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48000000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11000000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10000000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	237000000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	211000000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	108000000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	121000000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	10000000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	9000000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	7000000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	6000000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	111000000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	124000000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32000000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	29000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	79000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	95000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.49
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.08
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.45
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	79000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	95000000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11000000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10000000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	10000000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11000000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	14000000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-16000000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	30000000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	39000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	27000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-5000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-2000000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-5000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1000000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-77000000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Employee Related Liabilities IncreaseDecreaseInOtherEmployeeRelatedLiabilities	-60000000	usd
CY2024Q1	nsp	Increase Decreasein Wse Epayrollexpense IncreaseDecreaseinWSEEpayrollexpense	63000000	usd
CY2023Q1	nsp	Increase Decreasein Wse Epayrollexpense IncreaseDecreaseinWSEEpayrollexpense	12000000	usd
CY2024Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	25000000	usd
CY2023Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	26000000	usd
CY2024Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	-4000000	usd
CY2023Q1	us-gaap	Increase Decrease In Workers Compensation Liabilities IncreaseDecreaseInWorkersCompensationLiabilities	0	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-15000000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-46000000	usd
CY2024Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	12000000	usd
CY2023Q1	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	7000000	usd
CY2024Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-48000000	usd
CY2023Q1	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-55000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	31000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	40000000	usd
CY2024Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6000000	usd
CY2023Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	14000000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	6000000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	12000000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9000000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	23000000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	35000000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20000000	usd
CY2024Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-39000000	usd
CY2023Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	8000000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-83000000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-57000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-16000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1035000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1014000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	978000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	998000000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	4000000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2023Q4	us-gaap	Shares Issued SharesIssued	55000000	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	94000000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	23000000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10000000	usd
CY2024Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	21000000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	79000000	usd
CY2024Q1	us-gaap	Shares Issued SharesIssued	55000000	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	140000000	usd
CY2022Q4	us-gaap	Shares Issued SharesIssued	55000000	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	81000000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	35000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11000000	usd
CY2023Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	-1000000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	20000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	95000000	usd
CY2023Q1	us-gaap	Shares Issued SharesIssued	55000000	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	133000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	nsp	Percentageofourhealthinsurancecoverageprovidedby United PercentageofourhealthinsurancecoverageprovidedbyUnited	0.87
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	nsp	Number Of Days In Advance Of Beginning Of Reporting Quarter Carrier Establishes Cash Funding Rates NumberOfDaysInAdvanceOfBeginningOfReportingQuarterCarrierEstablishesCashFundingRates	P90D
CY2024Q1	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000	usd
CY2024Q1	nsp	Required Deposit For Health Care Costs RequiredDepositForHealthCareCosts	7000000	usd
CY2024Q1	nsp	Prepaid Health Insurance Current And Noncurrent PrepaidHealthInsuranceCurrentAndNoncurrent	33000000	usd
CY2024Q1	nsp	Prepaid Health Insurance Noncurrent PrepaidHealthInsuranceNoncurrent	9000000	usd
CY2024Q1	nsp	Prepaid Health Insurance Current PrepaidHealthInsuranceCurrent	24000000	usd
CY2024Q1	nsp	Premiums Owed To United PremiumsOwedToUnited	-63000000	usd
CY2024Q1	nsp	Benefits Costs Incurred Reduced Relatedto Runoff BenefitsCostsIncurredReducedRelatedtoRunoff	-18000000	usd
CY2023Q1	nsp	Benefits Costs Incurred Reduced Relatedto Runoff BenefitsCostsIncurredReducedRelatedtoRunoff	-9000000	usd
CY2019Q3	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	usd
CY2019Q3	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	usd
CY2019Q3	nsp	Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear	6000000	usd
CY2019Q3	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1000000	usd
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	usd
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	usd
CY2019Q4	nsp	Workers Compensation Maximum Aggregate Economic Burden For Claims In Excess Of First Layer Cap Per Policy Year WorkersCompensationMaximumAggregateEconomicBurdenForClaimsInExcessOfFirstLayerCapPerPolicyYear	6000000	usd
CY2019Q4	nsp	Workers Compensation Maximum Economic Burden First Layer Of Claims Per Occurrence WorkersCompensationMaximumEconomicBurdenFirstLayerOfClaimsPerOccurrence	1500000	usd
CY2024Q1	nsp	Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses	-9000000	usd
CY2023Q1	nsp	Decrease Increase In Accrued Workers Compensation Costs For Changes In Estimated Losses DecreaseIncreaseInAccruedWorkersCompensationCostsForChangesInEstimatedLosses	-8000000	usd
CY2024Q1	nsp	Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod	0.045
CY2023Q1	nsp	Us Treasury Rates That Correspond With Weighted Average Estimated Claim Payout Period USTreasuryRatesThatCorrespondWithWeightedAverageEstimatedClaimPayoutPeriod	0.040
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	220000000	usd
CY2022Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Opening Balance Adjustments LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseOpeningBalanceAdjustments	229000000	usd
CY2024Q1	nsp	Workers Compensation Expense WorkersCompensationExpense	14000000	usd
CY2023Q1	nsp	Workers Compensation Expense WorkersCompensationExpense	16000000	usd
CY2024Q1	nsp	Workers Compensation Discount Changed During Period WorkersCompensationDiscountChangedDuringPeriod	3000000	usd
CY2023Q1	nsp	Workers Compensation Discount Changed During Period WorkersCompensationDiscountChangedDuringPeriod	3000000	usd
CY2024Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	16000000	usd
CY2023Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	13000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	215000000	usd
CY2023Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	229000000	usd
CY2024Q1	nsp	Workers Compensation Liability Net Of Admin Fees Current WorkersCompensationLiabilityNetOfAdminFeesCurrent	60000000	usd
CY2023Q1	nsp	Workers Compensation Liability Net Of Admin Fees Current WorkersCompensationLiabilityNetOfAdminFeesCurrent	48000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	155000000	usd
CY2023Q1	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	181000000	usd
CY2024Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	215000000	usd
CY2023Q1	us-gaap	Workers Compensation Liability Current And Noncurrent WorkersCompensationLiabilityCurrentAndNoncurrent	229000000	usd
CY2024Q1	nsp	Workers Compensation Administrative Fees Accrued WorkersCompensationAdministrativeFeesAccrued	4000000	usd
CY2024Q1	nsp	Undiscounted Accrued Workers Compensation Costs UndiscountedAccruedWorkersCompensationCosts	247000000	usd
CY2023Q1	nsp	Undiscounted Accrued Workers Compensation Costs UndiscountedAccruedWorkersCompensationCosts	253000000	usd
CY2024Q1	nsp	Time Period Incurred Claims Expected To Be Paid Recorded As Restricted TimePeriodIncurredClaimsExpectedToBePaidRecordedAsRestricted	P1Y
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	61000000	usd
CY2024Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	204000000	usd
CY2024Q1	nsp	Time Period Estimate Of Incurred Claim Costs To Be Paid Included In Short Term Liabilities TimePeriodEstimateOfIncurredClaimCostsToBePaidIncludedInShortTermLiabilities	P1Y
CY2024Q1	nsp	Unbilled Unbilled	712000000	usd
CY2023Q4	nsp	Unbilled Unbilled	669000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1802000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1770000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	nsp	Gross Billings GrossBillings	11483000000	usd
CY2023Q1	nsp	Gross Billings GrossBillings	11451000000	usd
CY2024Q1	nsp	Worksite Employee Payroll Cost WorksiteEmployeePayrollCost	9681000000	usd
CY2023Q1	nsp	Worksite Employee Payroll Cost WorksiteEmployeePayrollCost	9681000000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1802000000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1770000000	usd
CY2024Q1	nsp	Money Market Funds Overnight Holdings At Carrying Value MoneyMarketFundsOvernightHoldingsAtCarryingValue	356000000	usd
CY2023Q4	nsp	Money Market Funds Overnight Holdings At Carrying Value MoneyMarketFundsOvernightHoldingsAtCarryingValue	611000000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	134000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	135000000	usd
CY2024Q1	us-gaap	Cash Cash	212000000	usd
CY2023Q4	us-gaap	Cash Cash	27000000	usd
CY2024Q1	srt	Drafts Payable DraftsPayable	19000000	usd
CY2023Q4	srt	Drafts Payable DraftsPayable	64000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	683000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	709000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	nsp	Payroll Withholdings Included In Cash Balance PayrollWithholdingsIncludedInCashBalance	443000000	usd
CY2023Q4	nsp	Payroll Withholdings Included In Cash Balance PayrollWithholdingsIncludedInCashBalance	510000000	usd
CY2024Q1	nsp	Client Prepayments Included In Cash Balance ClientPrepaymentsIncludedInCashBalance	34000000	usd
CY2023Q4	nsp	Client Prepayments Included In Cash Balance ClientPrepaymentsIncludedInCashBalance	28000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	693000000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	733000000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	57000000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	50000000	usd
CY2023Q4	us-gaap	Funds Held For Clients FundsHeldForClients	87000000	usd
CY2022Q4	us-gaap	Funds Held For Clients FundsHeldForClients	35000000	usd
CY2023Q4	nsp	Deposits Workers Compensation DepositsWorkersCompensation	198000000	usd
CY2022Q4	nsp	Deposits Workers Compensation DepositsWorkersCompensation	196000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1035000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1014000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	667000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	697000000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	61000000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	48000000	usd
CY2024Q1	us-gaap	Funds Held For Clients FundsHeldForClients	46000000	usd
CY2023Q1	us-gaap	Funds Held For Clients FundsHeldForClients	42000000	usd
CY2024Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	204000000	usd
CY2023Q1	nsp	Deposits Workers Compensation DepositsWorkersCompensation	211000000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	978000000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	998000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	0	usd
CY2024Q1	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	650000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	700000000	usd
CY2024Q1	nsp	Percentage Of Subsidiary Stock Securing Debt PercentageOfSubsidiaryStockSecuringDebt	1	conversionratio
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	369000000	usd
CY2024Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	280000000	usd
CY2024Q1	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2027-06-30
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	nsp	Applicable Margin Federal Funds Rate ApplicableMarginFederalFundsRate	0.0050
CY2024Q1	nsp	Adjusted Term Sofr Rate Plus Applicable Margin AdjustedTermSOFRRatePlusApplicableMargin	0.0200
CY2024Q1	us-gaap	Line Of Credit Facility Unused Capacity Commitment Fee Percentage LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage	0.0025
CY2024Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.072
CY2024Q1	nsp	Aggregatenumberofsharesrepurchasedduringtheperiod Aggregatenumberofsharesrepurchasedduringtheperiod	232891	shares
CY2024Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	53744	shares
CY2024Q1	us-gaap	Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased	1915818	shares
CY2024Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	179147	shares
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.57
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21000000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	20000000	usd
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	79000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	95000000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38000000	shares
CY2024Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38000000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39000000	shares
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Type DocumentType	10-Q

Files In Submission

Name	View Source	Status
0001000753-24-000034-index-headers.html	Edgar Link	pending
0001000753-24-000034-index.html	Edgar Link	pending
0001000753-24-000034.txt	Edgar Link	pending
0001000753-24-000034-xbrl.zip	Edgar Link	pending
a03312024nsp-ex101sixthame.htm	Edgar Link	pending
a03312024nsp-ex311.htm	Edgar Link	pending
a03312024nsp-ex312.htm	Edgar Link	pending
a03312024nsp-ex321.htm	Edgar Link	pending
a03312024nsp-ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nsp-20240331.htm	Edgar Link	pending
nsp-20240331.xsd	Edgar Link	pending
nsp-20240331_g1.jpg	Edgar Link	pending
nsp-20240331_g10.jpg	Edgar Link	pending
nsp-20240331_g11.jpg	Edgar Link	pending
nsp-20240331_g2.jpg	Edgar Link	pending
nsp-20240331_g3.jpg	Edgar Link	pending
nsp-20240331_g4.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
nsp-20240331_cal.xml	Edgar Link	unprocessable
nsp-20240331_def.xml	Edgar Link	unprocessable
nsp-20240331_g5.jpg	Edgar Link	pending
nsp-20240331_g6.jpg	Edgar Link	pending
nsp-20240331_g7.jpg	Edgar Link	pending
nsp-20240331_g8.jpg	Edgar Link	pending
nsp-20240331_g9.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nsp-20240331_htm.xml	Edgar Link	completed
nsp-20240331_pre.xml	Edgar Link	unprocessable
nsp-20240331_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NSP
INSPERITY, INC. Stock $nsp

2024 Q2 Form 10-Q Financial Statement

#000100075324000034 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSP INSPERITY, INC. Stock $nsp

2024 Q2 Form 10-Q Financial Statement

#000100075324000034 Filed on May 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSP
INSPERITY, INC. Stock $nsp